Article
Prognostic implications of c-Ki-ras2 mutations in patients with advanced colorectal cancer treated with 5-fluorouracil and interferon: a study of the eastern cooperative oncology group (EST 2292)
The cancer journal from Scientific American - 1 Jan 2000
Wadler S, Bajaj R, Neuberg D, Agarwal V, Haynes H, Benson A B
Abstract excerpt
PURPOSE: Mutations in c-Ki-ras2 (ras) occur in about 40% of patients with colorectal cancers and occur early in the pathogenesis of this disease. To evaluate the prognostic value of mutations in ras, the Eastern Cooperative Oncology Group (ECOG) conducted a retrospective study (EST 2292) to determine the frequency of mutations in patients with advanced colorectal cancer, and to determine whether ras mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.